The invention relates to a bioactive fraction of Petiveria alliacea having an antitumour activity, and to the use of same for producing medicaments for treating cancer. The invention also relates to a pharmaceutical combination for treating, comprising the bioactive fraction of Petiveria alliacea and at least one immunostimulant that can produce the phenotypic and/or functional maturation of the dendritic cells. The invention further relates to sequential administration of the bioactive fraction of Petiveria alliacea or the composition containing same and immunostimulant agent.
本发明涉及一种具有抗肿瘤活性的蝶形花
生物活性成分,以及使用该成分生产治疗癌症的药物。本发明还涉及一种用于治疗的药物组合,其中包括芍药的
生物活性成分和至少一种可促进树突状细胞表型和/或功能成熟的免疫刺激剂。本发明还涉及连续给药小苍兰
生物活性成分或含有该成分的组合物和免疫刺激剂。